A randomized, double-blind, placebo-controlled phase 3 study of the relative efficacy and tolerability of tapentadol IR and oxycodone IR for acute pain.

Source:http://linkedlifedata.com/resource/pubmed/id/19445652

Download in:

View as

General Info

PMID
19445652